CD8A and neoplasm: Within the tumor microenvironment, Tregs have an opposing action to cytotoxic CD8 T cells (8), and reducing the number of Tregs was found to reinvigorate anti-tumor immunity and promote tumor regression in different types of cancer (9–14).